Retinoic Acid

Specifications

302-79-4CAS Number

206-129-0EC Number

(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acidIUPAC Name

C20H28O2Chemical Formula

300.4 g/molMolecular Weight

Retinoic acid; tretinoin; 302-79-4; all-trans-Retinoic acid; Vitamin A acid; trans-Retinoic acid; ATRA; Aberel; Eudyna; Dermairol; Renova; all-trans-Vitamin A acid; Cordes vas; Retin A; Tretin M; all-trans-Tretinoin; Retionic acid; all-trans-Vitamin A1 acid; beta-Ra; Retin-A Micro; Vitamin A1 acid, all-trans-; beta-Retinoic acid; Tretinoina; Atralin; all-(E)-Retinoic acid; All Trans Retinoic Acid; Vitamin A acid, all-trans-; NSC-122758; Retinoic acid, all-trans-; Betarretin; Tretinoinum; A-Acido (Argentina); all trans-Retinoic acid; Aberela [Norway]; Avitoin [Norway]; Acnavit [Denmark]; Effederm [France]; Kerlocal; Refissa; Oristar rna; all-trans-beta-Retinoic acid; Cordes VAS [Germany]; Retisol-A; Stieva-A; A-Vitaminsyre [Denmark]; DTXSID7021239; Tretinoin/All-Trans Retinoic Acid; (all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid; Acid A Vit (Belgium, Netherlands); ALTRENO; 2,4,6,8-Nonatetraenoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (all-E)-; Acid, all-trans-Retinoic; CHEBI:15367; 5688UTC01R; DTXCID001239; TWYNEO COMPONENT TRETINOIN; VELTIN COMPONENT TRETINOIN; Aberela (Norway); Avitoin (Norway); Acnavit (Denmark); Effederm (France); 3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-all-trans-tetraenoic acid; Cordes VAS (Germany); A-Vitaminsyre (Denmark); Acid, Retinoic; 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenoic acid; Acid, Vitamin A; 3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2E,4E,6E,8E-tetraenoic acid; trans Retinoic Acid; Acid, trans-Retinoic; Salt, Tretinoin Zinc; Zinc Salt, Tretinoin; Salt, Tretinoin Sodium; Sodium Salt, Tretinoin; Potassium Salt, Tretinoin; Salt, Tretinoin Potassium; beta all trans Retinoic Acid; Acid, beta-all-trans-Retinoic; Tretinoin Cream; Acide retinoique; Tretin-X; [All-E]-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid; RefChem:6318; RETIN-A-MICRO; 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid; Tretinoin (Microsphere); DERMAWERX ZMT PAK; D10AD01; L01XX14; ZINC OXIDE, MENTHOL, UNSPECIFIED FORM, and TRETINOIN; 3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid; 206-129-0; CHEBI:26536; Retin-A; Vesanoid; Airol; Aknoten; Epi-aberel; Aknefug; All-trans Retinoic Acid; TRETINON; (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid; Tretinoine; Alltrans-retinoic acid; Retinoate; Retacnyl; Vesnaroid; Ro 1-5488; Tretinoin, all-trans-; MFCD00001551; .beta.-Retinoic acid; RETINOIC ACID, ALL TRANS; 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid; (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid; MLS000028588; Retinoic acid (GMP); Tretinoine [INN-French]; Tretinoinum [INN-Latin]; AT-RA; Tretinoina [INN-Spanish]; Tretinoino [INN-Spanish]; CHEMBL38; (2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenoic acid; NSC122758; Retinova; SMR000058245; 15-Apo-beta-caroten-15-oic acid; AGN 100335; Retin A (TN); NCGC00017280-10; Acnavit; Tretinoino; A-Vitaminsyre; all-trans-b-Retinoic acid; 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ECL); trans-Retinoate; beta-Retinoate; tretinoine (French) (EINECS); cis-Retinoic acid; Acide retinoique (French) (DSL); Nexret; Vitamin a acid, trans-; LGD 100057; 11-cis,13-cis-Retinoic Acid >90%; 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2E,4E,6E,8E,-nonatetraenoic acid; 11-cis Retinoic Acid; 97950-17-9; Isotretinoin;(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid; [3H]Retinoic acid; NSC 122758; Renova (TN); CCRIS 3294; Avita (TN); HSDB 2169; SR-01000000239; EINECS 206-129-0; BRN 2057223; retinoicacid; Tretinoin (JAN/USP/INN); Tretinion; TNP00194; UNII-5688UTC01R; BML2-E05; s1653; Vitamine A acid; Tretinoin CRS; 1cbr; [3H]tretinoin; Tretinoin [USAN:USP:INN:BAN]; (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetr aenoic acid; CAS-302-79-4; Tretinoin; (2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenoic acid; Retinoic acid; Isotretinoin Impurity A; Prestwick_424; all-(E)-Retinoate; Tretinoine (French); Retinoic acid, cis-; [3H]Vitamin A acid; RETINOL_met006; 1n4h; CPD000058245; Retinoic acid all trans; TRETINOIN [INN]; TRETINOIN [JAN]; Retinoic Acid(Tretinoin); Retinoic?Acid(Tretinoin); TRETINOIN [HSDB]; TRETINOIN [USAN]; Vitamin-A-sA currencyure; Opera_ID_1055; Prestwick2_000257; Prestwick3_000257; Spectrum5_001746; Spectrum5_001933; Retinoic acid (Standard); TRETINOIN [VANDF]; acide retinoique (French); Vesanoid (TN) (Roche); bmse000562; TRETINOIN [MART.]; UPCMLD-DP097; R 2625; Renova (0.02% cream); RETINOIC ACID [MI]; SCHEMBL3145; TRETINOIN [USP-RS]; TRETINOIN [WHO-DD]; Altreno (0.05% lotion); BIDD:PXR0081; Epitope ID:2281341; Lopac0_001061; Avita (0.025% gel); BSPBio_000074; BSPBio_001500; MLS001076515; MLS002207234; MLS002222211; MLS002548861; MLS006010222; BIDD:GT0483; SPECTRUM1502016; 9-cis-retinoic acid (9cRA); Tretinoin - Bio-X trade mark; LGD 1057; NSC 659772; Panretin; Panretyn; Panrexin; Toctino; [3H]RA; BPBio1_000082; cid_444795; GTPL2644; orb1225380; orb1309934; orb3025128; SCHEMBL3732645; .beta.-all-trans-Retinoic acid; TRETINOIN [ORANGE BOOK]; ZIANA COMPONENT TRETINOIN; all-trans-retinoic acid (ATRA); TRETINOIN [EP MONOGRAPH]; BDBM31883; HMS502N05; SOLAGE COMPONENT TRETINOIN; all-trans-Retinoic acid/Tretinoin; TRETINOIN [USP MONOGRAPH]; BDBM323588; GLXC-07585; HMS1361K22; HMS1568D16; HMS1791K22; HMS1921D14; HMS1989K22; HMS2089D20; HMS2092N11; HMS2095D16; HMS2236N03; HMS3259E11; HMS3263E04; HMS3402K22; HMS3411B09; HMS3675B09; HMS3712D16; HMS5079B08; Pharmakon1600-01502016; Retinoic acid, all-trans- (8CI); 2,4,6,8-Nonatetraenoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (2E,4E,6Z,8E)-; MSK10487; TRI-LUMA COMPONENT TRETINOIN; US10188615, at-RA; Retinoic acid, Isotretinoin Impurity; Tox21_110812; Tox21_202330; Tox21_300305; Tox21_501061; CCG-39912; EBC-11075; HY-14649G; HY-14649R; LMPR01090019; NSC759631; SBB065722; AKOS000280845; Isotretinoin EP Impurity A; Tretinoin; Tox21_110812_1; AC-6824; CS-1269; DB00755; FR17921; GS-3578; LP01061; NC00481; NSC-759631; SDCCGSBI-0051031.P004; IDI1_000903; IDI1_033970; NCGC00017280-05; NCGC00017280-06; NCGC00017280-07; NCGC00017280-08; NCGC00017280-09; NCGC00017280-12; NCGC00017280-15; NCGC00017280-16; NCGC00017280-17; NCGC00017280-18; NCGC00017280-19; NCGC00017280-20; NCGC00017280-23; NCGC00017280-33; NCGC00017280-38; NCGC00021808-04; NCGC00021808-05; NCGC00021808-06; NCGC00021808-07; NCGC00021808-09; NCGC00021808-11; NCGC00021808-14; NCGC00021808-15; NCGC00254179-01; NCGC00259879-01; NCGC00261746-01; BP-20401; BR164493; HY-14649; Retinoic acid, >=98% (HPLC), powder; ST057075; SY030154; SBI-0051031.P003; CS-0626116; EU-0101061; ISOTRETINOIN IMPURITY A [EP IMPURITY]; R0064; R1780; SW203749-4; C00777; D00094; Q29417; AB00052318-15; AB00052318-16; AB00052318-17; AB00052318_18; AB00052318_19; EN300-27107561; F317904; F570782; L000833; SR-01000000239-3; SR-01000000239-4; SR-01000000239-6; SR-01000000239-7; BRD-K06926592-001-01-7; BRD-K71879491-001-15-0; BRD-K71879491-001-22-6; BRD-K71879491-001-37-4; BRD-K71879491-001-38-2; BRD-K71879491-001-39-0; BRD-K71879491-001-44-0; BRD-K71879491-001-47-3; BRD-K71879491-001-48-1; SR-01000000239-12; SR-01000000239-13; SR-01000000239-14; SR-01000000239-15; WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U1VQ C1 C1; Tretinoin, European Pharmacopoeia (EP) Reference Standard; WLN: L6UTJ A1 B1U1Y1 & U2U1Y1 & U1VQ C1 C1; Tretinoin, United States Pharmacopeia (USP) Reference Standard; 3,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid; Tretinoin, Pharmaceutical Secondary Standard; Certified Reference Material; (8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid; (all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoate; 2,4,6,8-Nonatetranoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-; 2,6,8-Nonatetranoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-; 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoate; all-trans-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic Acid; 2,4, 6,8-Nonatetranoic acid, 3,7-dimethyl-9-(2,6, 6-trimethyl-1-cyclohexen-1-yl)-, (2E, 4E, 6E, 8E)-; 2,4,6,8-Nonatetraenoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)--, (all trans)-; 2,4,6,8-Nonatetranoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (all trans)-; 2,6,8-Nonatetraenoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (all-E)-; 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid-, (all trans)-Synonyms